CSTI-300 (SMP-100); a Novel 5-HT<sub>3</sub>Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
The journal of pharmacology and experimental therapeutics/The Journal of pharmacology and experimental therapeutics